Letter to the Editor
-
Issue: Ahead-of-Print
Publication Date: 2023-07-31
A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells
-
Issue: Ahead-of-Print
Publication Date: 2023-06-12
Significant neutropenia induced by metamizole dependent neutrophil antibodies
-
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August)
Publication Date: 2023-04-13
Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy
-
Issue: Blood Transfusion - 2 2019 (March-April)
Publication Date: 2022-12-02
A case of dabigratan-related acute agranulocytosis
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-07-22
COVID-19 vaccination, anticoagulation level and warfarin treatment
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-07-22
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-07-22
Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure
-
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August)
Publication Date: 2022-06-07
A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test
-
Issue: Blood Transfusion - 3 2022 (May-June)
Publication Date: 2021-09-22
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic
-
Issue: Blood Transfusion - 2 2022 (March-April)
Publication Date: 2021-03-30
Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing
-
Issue: Blood Transfusion - 2 2022 (March-April)
Publication Date: 2021-03-30
Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management
-
Issue: Blood Transfusion - 2 2021 (March-April)
Publication Date: 2020-12-23
Making friends out of foes: novel therapeutic approaches for haemophilia
-
Issue: Blood Transfusion - 2 2021 (March-April)
Publication Date: 2020-12-22
Appropriate red cell transfusions are often avoidable through Patient Blood Management
-
Issue: Blood Transfusion - 1 2021 (January-February)
Publication Date: 2020-11-12
On the association between the ABO blood group and COVID-19 susceptibility
-
Issue: Blood Transfusion - 1 2021 (January-February)
Publication Date: 2020-10-09
Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services
-
Issue: Blood Transfusion - 6 2020 (November-December)
Publication Date: 2020-09-18
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues
-
Issue: Blood Transfusion - 5 2020 (September-October)
Publication Date: 2020-07-29
Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders
-
Issue: Blood Transfusion - 4 2020 (July-August)
Publication Date: 2020-07-13
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy
-
Issue: Blood Transfusion - 4 2020 (July-August)
Publication Date: 2020-07-13
Therapeutic choices in persons with haemophilia at the time of COVID-19
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.
-
Issue: Blood Transfusion - 1 2018 (January - February)
Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light